· Life Sciences Careers
Moving from the bench to the business side of biotech
Eight business roles that hire former lab scientists, what each borrows from bench work, and how people make the switch without losing years.
Proteonomix: regenerative medicine, explained
Stem cells, cord blood and the science of repair, for curious readers.
Proteonomix explains how the body repairs itself and how medicine is learning to help it: stem cells and cord blood, cell therapies for diabetes and the heart, skin biology, and the tests every new treatment has to pass before it reaches a clinic.
Most of the cells in a transplant, a trial or a skin cream come with a story that is more interesting, and more uncertain, than the headline. We try to tell the whole story.
Our editors have worked in cell-culture labs, clinical research and biotech analysis. Every piece links to the studies and public sources behind it, says plainly what is proven and what is still experimental, and is checked again when the evidence changes.
Current topics in regenerative medicine
Some of the questions readers ask most often. Each explainer starts with the basics and ends with what the latest trials actually show.
Creams that mention stem cells, growth factors or secretomes are everywhere. Here is what those words mean on a label, what the lab studies looked at, and where the evidence stops.
Mesenchymal stromal cells grow readily in culture and calm inflammation in many experiments. Two decades of trials have taught researchers where they help and where they do not.
Replacing the insulin-making beta cells that the immune system destroys has been a goal since the 1990s. Lab-grown islet cells are now in human trials, with real progress and real hurdles.
More from the Science desk All pieces >
· Science & Society
Talking about stem cells in the classroom, with activities and discussion questions
A practical guide for teachers and curious students on stem cell science and ethics, with activities, discussion questions and sources worth trusting.
· Biotech Explained
CAR-T cell therapy in plain language, from collection day to the months after
What CAR-T cell therapy is, what happens from cell collection to infusion and recovery, its main side effects, costs, and where trials are heading next.
· Health Research
Organoids, the mini-organs in a dish: questions and answers
What organoids are, how they are grown, what gut, brain, kidney and tumor organoids are used for, where they fall short and how the rules are changing.
· Regenerative Medicine
Induced pluripotent stem cells explained: how adult cells are wound back to the start
How four genes turned adult cells into pluripotent stem cells, what iPSCs are used for, the first patients treated and the safety questions still open.
· Business & Investing
Why most drugs fail between phase 2 and approval
Phase 2 is where most experimental drugs stop. The numbers behind that, the main reasons, and what they mean when you read trial news.
Proteonomix start here
Who writes this?
Five editors with lab, clinic and industry backgrounds. Meet them and read how we handle medical topics.
What do we cover?
Regenerative medicine, biotech, health research and the people and money behind them.
Reference explainers
- Stem cell technology, explained: from isolation to the freezer
- Bone marrow stromal cells (MSCs): what they are and what two decades of trials show
- Growing more stem cells from one cord: ex vivo expansion and graft engineering
- Stem cell skincare: what growth factor and secretome labels really mean
- Cord blood banking: public, private and hybrid models explained
- Which conditions are treated with cord blood transplants?
- Stem cells and type 1 diabetes: where the research stands
- Cell therapy after a heart attack: what two decades of trials found
- For clinicians: talking with patients about stem cell clinics
- Careers in the life sciences: a map for students and career changers
- How to read a biotech company's filings: a plain guide for investors
- Translational medicine: how a lab discovery reaches the clinic